JP7425092B2 - 抗線維化剤、及び抗線維化作用を有する細胞外小胞の製造方法 - Google Patents
抗線維化剤、及び抗線維化作用を有する細胞外小胞の製造方法 Download PDFInfo
- Publication number
- JP7425092B2 JP7425092B2 JP2021571238A JP2021571238A JP7425092B2 JP 7425092 B2 JP7425092 B2 JP 7425092B2 JP 2021571238 A JP2021571238 A JP 2021571238A JP 2021571238 A JP2021571238 A JP 2021571238A JP 7425092 B2 JP7425092 B2 JP 7425092B2
- Authority
- JP
- Japan
- Prior art keywords
- extracellular vesicles
- derived
- affinity
- solution
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Hematology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020004765 | 2020-01-15 | ||
| JP2020004765 | 2020-01-15 | ||
| PCT/JP2021/001131 WO2021145395A1 (ja) | 2020-01-15 | 2021-01-14 | 抗線維化剤、及び抗線維化作用を有する細胞外小胞の製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2021145395A1 JPWO2021145395A1 (cg-RX-API-DMAC7.html) | 2021-07-22 |
| JPWO2021145395A5 JPWO2021145395A5 (cg-RX-API-DMAC7.html) | 2022-09-08 |
| JP7425092B2 true JP7425092B2 (ja) | 2024-01-30 |
Family
ID=76864638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021571238A Active JP7425092B2 (ja) | 2020-01-15 | 2021-01-14 | 抗線維化剤、及び抗線維化作用を有する細胞外小胞の製造方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220362290A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4091617A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7425092B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN115361956A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021145395A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022080461A1 (ja) * | 2020-10-16 | 2022-04-21 | 富士フイルム和光純薬株式会社 | 細胞外小胞の産生用培地、培地キット、添加剤及び細胞外小胞の産生方法 |
| CN114306278A (zh) * | 2021-12-30 | 2022-04-12 | 上海纳米技术及应用国家工程研究中心有限公司 | 一种EV装载CPP-siRNA纳米颗粒的制备方法及其产品和应用 |
| CN117899007A (zh) * | 2024-01-22 | 2024-04-19 | 华北理工大学 | 一种负载ADSCs来源外泌体的水凝胶及其制备方法和应用 |
| CN119157906B (zh) * | 2024-09-30 | 2025-06-24 | 广州飞来爱生命科技有限公司 | 一种脐带间充质干细胞制剂及其在治疗肝脏疾病的用途 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016088689A1 (ja) | 2014-12-05 | 2016-06-09 | 和光純薬工業株式会社 | Timタンパク質結合担体、当該担体を用いた細胞外膜小胞及びウイルスの取得方法、除去方法、検出方法並びに当該担体を含むキット |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6035263A (ja) | 1983-08-05 | 1985-02-23 | Wako Pure Chem Ind Ltd | 不溶性担体に固定化された免疫活性物質の安定化法及び該物質を構成単位として含む生理活性物質測定用試薬 |
| US5200471A (en) | 1990-11-05 | 1993-04-06 | Minnesota Mining And Manufacturing Company | Biomolecules covalently immobilized with a high bound specific biological activity and method of preparing same |
| US8658374B2 (en) * | 2002-02-28 | 2014-02-25 | Microsens Biphage Limited | Binding of aggregated forms of proteins |
| WO2010107068A1 (ja) * | 2009-03-17 | 2010-09-23 | 和光純薬工業株式会社 | β-グルカンの測定方法及びそれに用いられるβ-グルカン結合性蛋白質 |
| WO2012039395A1 (ja) | 2010-09-24 | 2012-03-29 | 和光純薬工業株式会社 | small RNAの取得方法 |
| JP2016088689A (ja) | 2014-11-05 | 2016-05-23 | セイコーエプソン株式会社 | 媒体保持具、媒体装填装置、記録装置 |
| KR101844519B1 (ko) * | 2016-08-05 | 2018-04-02 | 한국생명공학연구원 | 섬유증 질환 모델의 제조방법 및 섬유증 질환 모델의 용도 |
| CN109891236A (zh) * | 2016-10-13 | 2019-06-14 | 合同会社明乐康中央研究所 | 回收胞外囊泡的方法 |
| CA3099042A1 (en) * | 2018-05-09 | 2019-11-14 | Children's Medical Center Corporation | Mesenchymal stromal cell exosome -treated monocytes and uses thereof |
-
2021
- 2021-01-14 EP EP21741345.9A patent/EP4091617A4/en active Pending
- 2021-01-14 WO PCT/JP2021/001131 patent/WO2021145395A1/ja not_active Ceased
- 2021-01-14 CN CN202180010028.1A patent/CN115361956A/zh active Pending
- 2021-01-14 JP JP2021571238A patent/JP7425092B2/ja active Active
-
2022
- 2022-07-15 US US17/865,875 patent/US20220362290A1/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016088689A1 (ja) | 2014-12-05 | 2016-06-09 | 和光純薬工業株式会社 | Timタンパク質結合担体、当該担体を用いた細胞外膜小胞及びウイルスの取得方法、除去方法、検出方法並びに当該担体を含むキット |
Non-Patent Citations (6)
| Title |
|---|
| FERGUSON, S. W., et al.,The microRNA regulatory landscape of MSC-derived exosomes: a systems view,Scinetific Reports,2018年,Vol.8, Article No.1419,pp.1-12,DOI:10.1038/s41598-018-19581-x |
| NAKAI, W., et al.,A novel affinity-based method for the isolation of highly purified extracellular vesicles,Scientific Reports,2016年,Vol.6, Article No.33935,pp.1-11,DOI: 10.1038/srep33935 |
| OHARA, M., et al.,Extracellular Vesicles from Amnion-Derived Mesenchymal Stem Cells Ameliorate Hepatic Inflammation and Fibrosis in Rats,Stem Cells International,2018年,Vol.2018, Article ID 3212643,pp.1-15,https://doi.org/10.1155/2018/3212643 |
| PHINNEY, D. G., et al.,Concise Review: MSC-Derived Exosomes for Cell-Free Therapy,Stem Cells,2017年,Vol.35, No.4,pp.851-858,http://dx.doi.org/10.1002/stem.2575 |
| TOLOMEO, A. M., et al.,Annexin a5(An5)-bound extracellular vesicles (EVs) from mesenchymal stromal cells (MSCs) show enhanced and specific antiinflammatory effects,J. Extracellular Vesicles,2018年,Vol.7, Supplement 1,p.10,DOI:10.1080/20013078.2018.1461450,ISSN: 2001-3078 |
| 山根 昌之 ほか,PSアフィニティー法が実現した高活性なMSC由来エクソソームの精製 -エクソソーム再生医療における全く新たな戦略の提案-,和光純薬時報,2020年10月15日,Vol.88, No.4,pp.10-11 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20220362290A1 (en) | 2022-11-17 |
| EP4091617A1 (en) | 2022-11-23 |
| EP4091617A4 (en) | 2023-08-09 |
| CN115361956A (zh) | 2022-11-18 |
| WO2021145395A1 (ja) | 2021-07-22 |
| JPWO2021145395A1 (cg-RX-API-DMAC7.html) | 2021-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230364150A1 (en) | Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids | |
| US20220362290A1 (en) | Anti-fibrosis agent and method of producing extracellular vesicle having anti-fibrosis action | |
| Li et al. | Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia | |
| US9877989B2 (en) | Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions | |
| AU2018335788B2 (en) | Methods and compositions for the treatment of epidermolysis bullosa | |
| JP2019517488A (ja) | 医学に使用するためのヒト血小板溶解物由来細胞外小胞 | |
| JP2023538109A (ja) | 骨髄由来間葉系幹細胞からの微小胞を使用する処置の組成物及び方法 | |
| Öztürk et al. | Immune regulation is more effective in the U937 inflammation model with mesenchymal stem cell extracellular vesicles stimulated by pro-inflammatory cytokines | |
| US12533381B2 (en) | Angiogenesis agent and method of producing extracellular vesicle having angiogenesis action | |
| JP7461382B2 (ja) | 抗炎症剤、及び抗炎症作用を有する細胞外小胞の製造方法 | |
| WO2021200299A1 (ja) | 細胞老化抑制剤、生体組織修復促進剤、遺伝子発現調節剤及び製造方法 | |
| Munshi et al. | Comprehensive Proteomic Analysis and Characterization of Human Bone Marrow Mesenchymal Stem/Stromal Derived Extracellular Vesicles | |
| Bharat et al. | Hepatic Stellate Cell Exosomes Resolve Fibrosis in Mice Livers via Enriched Metabolic and Regenerative Signaling Molecules | |
| HK40032447A (en) | Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids | |
| HK1263117A1 (en) | Human platelet lysate derived extracellular vesicles for use in medicine | |
| Tam | Investigating the Effects of Autophagic-Lysosomal Modulation on Extracellular Vesicles Derived from Neuronal, Astrocytic, and Microglial Cell Lines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220713 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220713 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230523 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230623 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230921 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20231226 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240118 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7425092 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R157 | Certificate of patent or utility model (correction) |
Free format text: JAPANESE INTERMEDIATE CODE: R157 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |